Stay updated with breaking news from Plasma Focus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™, the first clinically validated, tumor-informed, whole-genome sequencing circulating tumor DNA (ctDNA) molecular residual disease (MRD) solution in early stage colon cancer ...
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™,...
Nuclear fusion could be the answer to limitless clean energy, but there are major technological hurdles to clear first.
/PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted...
Liquid biopsy test for cancer patients enables oncologists to identify targeted therapies and improve care BURLINGTON, N.C., May 31, 2023 /PRNewswire/ -- Labcorp , a leading global life sciences... | June 7, 2023